About the Udall Center
The National Institute of Neurological Disorders and Stroke Morris K. Udall Parkinson's Disease Research Center of Excellence was launched at the Perelman School of Medicine (Penn) of the University of Pennsylvania in 2007. The competing renewal for years 6–10 of the Penn Udall Center builds on its recent progress to elucidate the progression of Parkinson's disease (PD) from normal cognition to cognitive impairment, executive dysfunction and dementia in PD with dementia (PDD), as well as disease progression in dementia with Lewy bodies (DLB), along with central nervous system (CNS) degeneration mediated by progressive accumulations of pathological alpha–synuclein.
The overarching goals of the Penn Udall Center are to elucidate mechanisms of disease progression and alpha–synuclein transmission through synergistic collaborations between basic and translational research.Read More
As one of ten Morris K. Udall Parkinson's Disease Research Centers of Excellence designated in the United States by the National Institute of Neurological Disorders and Stroke (NINDS), University of Pennsylvania researchers engaged in Parkinson's research are under one coordinated roof.
Penn Udall Center for Parkinson's Research collaborators include:
- Parkinson's Disease & Movement Disorders Center (PD&MC) at Pennsylvania Hospital
- Parkinson's Disease Research, Education & Clinical Center at the Philadelphia VA Medical Center (PADRECC)
- Penn Institute on Aging (IOA)
- Center for Neurodegenerative Disease Research (CNDR)
Udall Mission Statement
The mission of the Penn Udall is to conduct multidisciplinary clinical, translational, and basic research that improves understanding of and develops better treatments for patients with Parkinson's disease.
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.